ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2572

Recognition of  Spondyloarthritis By General Practitioners in Daily Practice and the Effect of Education on This; A Study with Standardized Patients

Marloes van Onna1, Simone Gorter2, Bas Maiburg3, Gerrie Waagenaar3 and Astrid van Tubergen4, 1Department of Internal Medicine, division of Rheumatology, Maastricht University Medical Center, division of Rheumatology, Maastricht, Netherlands, 2Department of Internal Medicine, division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of General Practice, Maastricht Univerisity, department of General Practice, Maastricht, Netherlands, 4Maastricht University Medical Center, Maastricht, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Education, medical, primary care and spondylarthropathy, Referrals

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Timely recognition and referral of patients with spondyloarthritis (SpA) is challenging due to the insidious disease onset and frequently unawareness of the clinical picture by primary care physicians. The aims of this study were to assess the current practice performance of general practitioners (GPs) and GP-residents in recognizing SpA, and to investigate the influence of education on this performance.

Methods: All GP-residents and their supervising GPs were visited in two rounds by standardized patients (SPs) during their regular outpatient clinic, simulating axial SpA (axSpA), peripheral SpA (perSpA) (i.e. dactylitis) or carpal tunnel syndrome (CTS), respectively. Participants were unaware of the nature of the medical problem and purpose of the study. CTS was included as a diversionary tactic. Each case was simulated by a male and a female, in random order, according to a predefined schedule. After the 1st round, half of the GP-residents were educated about SpA, as part of the GP specialty training without referring to the actual study. The other half of the GP-residents and all GPs served as controls. Next, all participants were visited by SPs again in the 2nd round. Participants ranked their differential diagnosis based on their probabilities (rank order: 1=most likely to 3=less likely) and indicated whether referral to a hospital physician would be appropriate. Descriptive statistics and chi-square tests were used to analyse the data.

Results: Sixty-eight (38 GP-residents (mean age 27.9 yrs, 32% male) and 30 GPs (mean age 52.5 yrs, 80% male) participated. Both rounds of SP-encounters were completed by 61 (90%) and 59 (87%) participants for the axSpA and perSpA case, respectively. Table 1 shows that axSpA was ranked as the no. 1 diagnosis by 12/61 (20%) participants, whereas perSpA was correctly diagnosed by none of participants in the 1st round. Participants who received the educational intervention, were more likely to rank axSpA and perSpA as the no. 1 diagnosis in the 2nd round when compared to the control group (axSpA 72% vs. 14% (p<0.001); perSpA 21% vs 3% (p=0.017)). All 18 participants, who received the educational intervention, listed axSpA in their differential diagnosis in the 2nd round and were more likely to refer the patient or considered referral to the rheumatologist optional (axSpA 77% vs. 25% (p<0.001); perSpA 53% vs. 5% (p<0.001)).

Conclusion: Patients with SpA are not adequately recognized by general practitioners. Providing an educational programme to GP-residents markedly improved the recognition of SpA and referral of patients with SpA to the rheumatologist.

 

 

Table 1. Pre- and post-intervention results of the educational and control group regarding diagnosis and referral of patients suspected for axial and peripheral spondyloarthritis

 

Educational intervention (yes vs no)

Diagnosis and referral of SPs

Round 1 (%)

Round 2 (%)

 

 

 

 

 

Axial SpA

(n = 61)

 

 

Educational intervention

(n = 18)

Ranked axial SpA as no. 1 diagnosis

4 (22)

13 (72)

Ranked axial SpA in differential diagnosis (no. 1, 2 or 3)

12 (66)

18 (100)

Referral rheumatologist

1 (6)

6 (33)

Referral rheumatologist optional

0 (0)

8 (44)

 

 

No educational intervention (n = 43)

Ranked axial SpA as no. 1 diagnosis

8 (19)

6 (14)

Ranked axial SpA in differential diagnosis (no 1, 2 or 3)

22 (51)

33 (77)

Referral rheumatologist

2 (5)

4 (9)

Referral rheumatologist optional

2 (5)

7 (16)

 

 

Educational intervention (yes vs no)

Diagnosis and referral SPs

Round 1 (%)

Round 2 (%)

 

 

 

 

 

 

Peripheral SpA

(n = 59)

 

 

 

Educational intervention

(n = 19)

Ranked peripheral SpA as no. 1 diagnosis

0 (0)

4 (21)

Ranked peripheral SpA in differential diagnosis (no. 1, 2 or 3)

0 (0)

5 (26)

Referral rheumatologist

1 (0)

8 (42)

Referral rheumatologist optional

0 (0)

2 (11)

 

 

No educational intervention (n = 40)

Ranked peripheral SpA as no. 1 diagnosis

0 (0)

1 (3)

Ranked peripheral SpA in differential diagnosis (no. 1, 2 or 3)

2 (5)

1 (3)

Referral rheumatologist

2 (5)

1 (2)

Referral rheumatologist optional

0 (0)

1 (2)

SPs = standardized patients, SpA = spondyloarthritis. Values are expressed as number (percentage) of participants.

 

 

 


Disclosure:

M. van Onna,
None;

S. Gorter,
None;

B. Maiburg,
None;

G. Waagenaar,
None;

A. van Tubergen,

AbbVie, Pfizer, UCB,

5,

MSD, Pfizer, AbbVie, Roche,

2,

AbbVie, MSD, UCB, Pfizer,

9.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/recognition-of-spondyloarthritis-by-general-practitioners-in-daily-practice-and-the-effect-of-education-on-this-a-study-with-standardized-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology